These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28521022)

  • 21. Brugada phenocopy with a flecainide overdose: a pharmacological dose effect?
    Chubb H; Cooklin M; Rosenthal E
    J Cardiovasc Electrophysiol; 2014 May; 25(5):547-548. PubMed ID: 24303843
    [No Abstract]   [Full Text] [Related]  

  • 22. ST-Elevation Magnitude Correlates With Right Ventricular Outflow Tract Conduction Delay in Type I Brugada ECG.
    Leong KMW; Ng FS; Yao C; Roney C; Taraborrelli P; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Boon Lim P; Harding SE; Peters NS; Kanagaratnam P; Varnava AM
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores.
    Tadros R; Tan HL; ; El Mathari S; Kors JA; Postema PG; Lahrouchi N; Beekman L; Radivojkov-Blagojevic M; Amin AS; Meitinger T; Tanck MW; Wilde AA; Bezzina CR
    Eur Heart J; 2019 Oct; 40(37):3097-3107. PubMed ID: 31504448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological Provocation of Outflow-Tract Tachycardia in a Patient With Brugada Syndrome.
    Bürkle G; Schäfer H; Marschall C; Brugada P; Ehrlich JR
    Can J Cardiol; 2016 Dec; 32(12):1577.e5-1577.e7. PubMed ID: 27032887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers.
    Lu HR; Rohrbacher J; Vlaminckx E; Van Ammel K; Yan GX; Gallacher DJ
    Br J Pharmacol; 2010 May; 160(1):60-76. PubMed ID: 20331615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical state transitions during advanced life support (ALS) in in-hospital cardiac arrest.
    Nordseth T; Bergum D; Edelson DP; Olasveengen TM; Eftestøl T; Wiseth R; Abella BS; Skogvoll E
    Resuscitation; 2013 Sep; 84(9):1238-44. PubMed ID: 23603153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome.
    Meregalli PG; Ruijter JM; Hofman N; Bezzina CR; Wilde AA; Tan HL
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):857-64. PubMed ID: 16764707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Report of Brugada Syndrome Presenting with Cardiac Arrest Triggered by Verapamil Intoxication.
    Yakut K; Erdoğan İ; Varan B; Atar İ
    Balkan Med J; 2017 Dec; 34(6):576-579. PubMed ID: 29215340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations.
    Hong K; Brugada J; Oliva A; Berruezo-Sanchez A; Potenza D; Pollevick GD; Guerchicoff A; Matsuo K; Burashnikov E; Dumaine R; Towbin JA; Nesterenko V; Brugada P; Antzelevitch C; Brugada R
    Circulation; 2004 Nov; 110(19):3023-7. PubMed ID: 15520322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome.
    Ikeda T; Abe A; Yusu S; Nakamura K; Ishiguro H; Mera H; Yotsukura M; Yoshino H
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):602-7. PubMed ID: 16836706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
    Wolpert C; Echternach C; Veltmann C; Antzelevitch C; Thomas GP; Spehl S; Streitner F; Kuschyk J; Schimpf R; Haase KK; Borggrefe M
    Heart Rhythm; 2005 Mar; 2(3):254-60. PubMed ID: 15851314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.
    Obeyesekere MN; Klein GJ; Modi S; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Krahn AD
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):958-64. PubMed ID: 22203660
    [No Abstract]   [Full Text] [Related]  

  • 36. Insight into specific pro-arrhythmic triggers in Brugada and early repolarization syndromes: results of long-term follow-up.
    Talib AK; Sato N; Myojo T; Sugiyama E; Nakagawa N; Sakamoto N; Tanabe Y; Fujino T; Takeuchi T; Akasaka K; Matsuhashi H; Saijo Y; Kawamura Y; Doi A; Hasebe N
    Heart Vessels; 2016 Dec; 31(12):2035-2044. PubMed ID: 26968993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome.
    Nademanee K; Veerakul G; Nogami A; Lou Q; Hocini M; Coronel R; Behr ER; Wilde A; Boukens BJ; Haissaguerre M
    Heart Rhythm; 2022 Mar; 19(3):407-416. PubMed ID: 34742919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac arrest with refractory ventricular fibrillation: a successful resuscitation using extracorporeal membrane oxygenation.
    Chiu CC; Chiu CW; Chen YC; Siao FY
    Am J Emerg Med; 2013 Jan; 31(1):264.e1-2. PubMed ID: 22633715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome.
    Madias JE
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E32; author reply E33. PubMed ID: 18298519
    [No Abstract]   [Full Text] [Related]  

  • 40. The ajmaline challenge and a strange ECG.
    Martini B
    Europace; 2009 Oct; 11(10):1406; author reply 1406-7. PubMed ID: 19797154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.